FDA Releases Final Guidance on Deemed License Provision of BPCI Act

Summary

The FDA has released a final guidance to address questions and provide clarity on its implementation of the Biologics Price Competition and Innovation Act's 'deemed to be a license' provision, which went into effect on March 23, 2020, for biological products approved under the FD&C Act.